)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Diaceutics
Diaceutics (DXRX) investor relations material
Diaceutics H1 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 TU earnings summary29 Jul, 2026
Executive summary
Revenue for H1 2026 grew 22% at constant currency to £17.5 million, with a 3-year CAGR of 21%.
Annual Recurring Revenue (ARR) surged 75% year-over-year to £28.8 million, with recurring revenue now 61% of total TTM revenues.
Order book expanded 38% to £43.7 million, with £15.7 million contracted for H2 2026 delivery, providing 91% visibility on FY 2026 consensus revenue.
Customer base grew to 54 across 99 therapeutic brands, with deepening relationships and longer-term contracts.
Financial highlights
H1 2026 revenue: £17.5 million (H1 2025: £14.6 million), up 20% year-over-year.
Gross margin increased to 87% (H1 2025: 83%).
Adjusted EBITDA expected at £1.1 million, up from £0.1 million in H1 2025.
Cash position at £8.1 million with no debt as of 30 June 2026.
Outlook and guidance
91% visibility on achieving FY 2026 median analyst consensus revenue estimates of £46.7 million.
Management confident in meeting 2026 targets, supported by recurring revenue, order book, and pipeline.
Focus remains on disciplined organic growth, recurring revenue expansion, cash conversion, and cost control.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Diaceutics
- 24% revenue growth, 87% gross margin, and PMx launch set stage for 2025 profitability.DXRX
H1 20248 Jul 2026 - 24% revenue growth, 80% EBITDA rise, and record order book drive strong 2026 outlook.DXRXH2 20255 Jun 2026
- FY 2025 saw 24% revenue growth, margin expansion, and record ARR, driven by platform and market gains.DXRXCorporate presentation26 May 2026
- AI-powered DXRX platform drives high-margin recurring revenue and ROI in precision medicine.DXRXCME 20241 Feb 2026
- 20% revenue growth, record ARR, and strong FY 2026 outlook amid expanding partnerships.DXRXQ4 2025 TU15 Jan 2026
- 39% revenue growth, 88% margin, and US expansion drive 2025 profitability shift.DXRXH2 202418 Nov 2025
- Revenue up 22% to £14.6m, ARR up 16%, and positive EBITDA signal profitability on track.DXRXH1 202523 Sep 2025
- 22% revenue growth, rising recurring revenues, and strong pipeline underpin FY 2025 confidence.DXRXTrading Update22 Jul 2025
- Revenue up 24% in H1 2024, with 55% recurring and strong growth in enterprise engagements.DXRXTrading Update13 Jun 2025
Next Diaceutics earnings date
H1 202623 Sep, 2026
Diaceutics
Next Diaceutics earnings date
H1 202623 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage